GWMR
VRTX icon

GC Wealth Management RIA’s Vertex Pharmaceuticals VRTX Stock Holding History

GC Wealth Management RIA’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$391K Sell
788
-234
-23% -$104K 0.02% 372
2026
Q1 		$456K Sell
1,022
-200
-16% -$93.3K 0.02% 361
2025
Q4 		$554K Sell
1,222
-2,110
-63% -$909K 0.02% 341
2025
Q3 		$1.3M Buy
3,332
+1,567
+89% +$655K 0.04% 272
2025
Q2 		$786K Buy
1,765
+1,314
+291% +$606K 0.06% 240
2025
Q1 		$219K Buy
+451
New +$210K 0.04% 292

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

GC Wealth Management RIA's VRTX Position: Q2 2026 in Review

GC Wealth Management RIA reduced its Vertex Pharmaceuticals (VRTX) stake by 23% in Q2 2026, selling an estimated $104K and leaving 788 shares worth $391K. The position accounts for 0.02% of the portfolio, ranked #372.

GC Wealth Management RIA first reported a position in VRTX in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.3M in Q3 2025. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • GC Wealth Management RIA held 788 shares of Vertex Pharmaceuticals worth $391K as of Q2 2026.
  • GC Wealth Management RIA sold 234 Vertex Pharmaceuticals shares in Q2 2026, an estimated $104K.
  • Vertex Pharmaceuticals made up 0.02% of GC Wealth Management RIA's portfolio in Q2 2026, its #372 holding.
  • GC Wealth Management RIA first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • GC Wealth Management RIA's Vertex Pharmaceuticals position peaked at $1.3M in Q3 2025.
  • 334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on GC Wealth Management RIA's 13F filing for Q2 2026, filed 16 Jul 2026.